Operating

Change in AP

Eli Lilly Change in AP remained flat by 0.0% to $2.55B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 290.5%, from $652.25M to $2.55B. Over 4 years (FY 2021 to FY 2025), Change in AP shows an upward trend with a 78.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025Feb 12, 2026

How to read this metric

An increase is generally positive for cash flow, as it allows the company to retain cash longer, provided it does not damage supplier relationships.

Detailed definition

This measures the change in the amount the company owes to its suppliers and vendors for goods and services received. An...

Peer comparison

Standard metric; companies often aim to optimize payment terms to maximize cash availability.

Metric ID: change_in_accounts_payable

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value-$1.01B$1.69B$4.27B$2.61B$10.19B
YoY Change+266.9%+152.6%-39.0%+290.5%
Range-$1.01B$10.19B
CAGR+78.0%
Avg YoY Growth+167.7%
Median YoY Growth+209.7%

Frequently Asked Questions

What is Eli Lilly's change in ap?
Eli Lilly (LLY) reported change in ap of $2.55B in Q4 2025.
How has Eli Lilly's change in ap changed year-over-year?
Eli Lilly's change in ap increased by 290.5% year-over-year, from $652.25M to $2.55B.
What is the long-term trend for Eli Lilly's change in ap?
Over 4 years (2021 to 2025), Eli Lilly's change in ap has grown at a 78.0% compound annual growth rate (CAGR), from -$1.01B to $10.19B.
What does change in ap mean?
The change in money the company owes to its suppliers.